|
PU-WS13 (CAS: 1454619-14-7)
|
| SKU-Pack Size | Availability | Size | Price | |
| EBC51017-1ML | In Stock | 1mL(10mM in DMSO) | €154.70 | |
| EBC51017-5MG | In Stock | 5mg | €115.70 | |
| EBC51017-10MG | In Stock | 10mg | €180.70 | |
| EBC51017-50MG | In Stock | 50mg | €635.70 |
| Please Select The Country You Are In To Find Your Local Distributor. |
| SBT BioChem Srl | Phone£º+39 05 7156 8147 | |
| Via Ponte di Bagnolo, 811 Bologna, | E-mail£ºinfo@sbtbiochem.it | |
| Italy | Italy | Web£ºwww.sbtbiochem.it |
| Product Information | |||||||||||||||||||||
| Synonym(s) | Grp94 inhibitor | ||||||||||||||||||||
| Chemical Name | 8-((3,5-dichlorophenyl)thio)-9-(3-(isopropylamino)propyl)-9H-purin-6-amine | ||||||||||||||||||||
| Application | Pu-ws13 is a selective GRP94 inhibitor | ||||||||||||||||||||
| CAS Number | 1454619-14-7 | ||||||||||||||||||||
| Purity | ¡Ý99.0% | ||||||||||||||||||||
| Molecular Weight | 411.35 | ||||||||||||||||||||
| Molecular Formula | C₁₇H₂₀Cl₂N₆S | ||||||||||||||||||||
| SMILES | CC(NCCCN1C(SC2=CC(Cl)=CC(Cl)=C2)=NC3=C(N)N=CN=C13)C | ||||||||||||||||||||
| Target & IC50 | GRP94: EC50 = 0.22 ¦ÌM HSP90¦Á: EC50 = 27.3 ¦ÌM HSP90¦Â: EC50 = 41.8 ¦ÌM |
||||||||||||||||||||
| Solubility | DMSO : 40 mg/mL (97.24 mM) | ||||||||||||||||||||
| Preparing Stock Solutions |
|
||||||||||||||||||||
| Shipping | Gel Pack | ||||||||||||||||||||
| Storage | Store at -20¡ã C | ||||||||||||||||||||
| Research Use | For Research Use Only. Not Intended for Diagnostic or Therapeutic Use. | ||||||||||||||||||||
| Product Description | |
PU-WS13 is a Grp94 inhibitor, with an EC50 of 0.22 μM. PU-WS13 also slightly suppresses Hsp90α, Hsp90β and Trap-1, with EC50s of 27.3, 41.8 and 7.3 μM, respectively. PU-WS13 (2.5-20 μM) shows no toxicity on two nonmalignant cell lines. PU-WS13 (15 μM) disrupts the circular architecture of HER2 at the plasma membrane of SKBr3 cells mediated through Grp94. PU-WS13 inhibits Grp94, and the inhibition induces apoptosis in and reduce the viability of HER2 overexpressing breast cancer cells |
| Specific Protocols | |